 (Chest 1995; 1071045-48) 
positive until proven otherwise, it can be argued that the equipment and tubing must be decontaminated between each patient.3 Yet, considering the high patient workload of most laboratories, this approach is largely impractical. A better solution would be to prevent the contamination of the equipment. This approach has been taken by one laboratory that has introduced elaborate techniques to prevent expired breath from entering equipment,4 but these techniques do not appear to have been widely adopted.5
A more attractive preventive strategy is to use a disposable filter to protect the equipment from contamination.5'6 A disposable microaerosol barrier filter has been developed for in-line use during lung function testing (PF30S, Pall Bio-medical, Portsmouth, United Kingdom). The filter consists of three layers of pleated polypropylene that is reported to reduce the chance of cross-infection to negligible levels by acting as a barrier to exhaled and inhaled droplets. 5 The efficiency of the filter at removing exhaled bacteria has been confirmed by several studies2'6 and it can be expected that the transmission of viral and fungal vectors would also be reduced to negligible levels. Previous studies, which have investigated the effect of the filter on the measurement of ventilatory capacity in children and adolescents7 and in one normal subject,8 concluded that although expired flows and volumes were reduced, the reduction was not clinically significant. No study appears to have determined the effect of the filter on other lung function indices such as diffusing capacity where the resistance of the filter and additional 55 mL of dead-space could potentially alter lung physiology and the associated calculation algorithms.
The aims of this study were to examine the resistance characteristics and to determine the effect of the microaerosol barrier filter (PF30S) on the clinical measurement of detailed lung function.
METHODS

Resistance Characteristics
The 
RESULTS
Resistance Characteristics
The flow resistance of the filter (mean ±SD) was 0.19±0.02 cm H20/L/s at 1 L/s, decreased slightly to 0.18±0.01 cm H20/L/s at 2 L/s, and then increased linearly to 0.56 ± 0.02 cm H20/L/s at 12 L/s (Fig 1) . After use, the resistance of the filters at 12 L/s increased by only 0.01 ± 0.002 cm H20/L/s, which was not significant. The resistance characteristics of different filters was similar with a mean coefficient of variation over the flow range 1 to 12 L/s of 4.6%.
At 12 L/s, the resistance of the pneumotachograph system was 0.87 cm H20/L/s (Fig 1) and with the filter attached it increased to 1.43 cm H20/L/s. Thus, the pneumotachograph system with the filter attached was within the upper limit (1.5 cm H20/L/s at 12 L/s) recommended by the ATS for the measurement of spirometry.1" Effect on the Measurement of Lung Function
The addition of the filter to the testing circuit was well tolerated by all patients despite the increase in resistance and 55 mL of dead-space of the breathing circuit. However, three patients did comment that they had difficulty maintaining a tight seal around the plastic port of the filter.
The effect of the filter on lung function measurements is given in Table 1 and shows that its addition to the breathing circuit caused a significant decrease in FEV, and PEFR with all other indices remaining unchanged. The mean change in FEV, was -0.044 ± 0.08 L (p=0.014) and PEFR was -0.47 ± 0.073 L/s (p=0.004). There were no significant correlations between the change in FEV, or PEFR and the degree of airflow limitation as defined by the baseline FEV,/FVC%. DISCUSSION This study shows that the addition of the microaerosol barrier filter-(PF30S) to the breathing circuit does not significantly affect the measurement of single breath Dco, KCO, and VA, and plethysmographically determined RV, TGV, TLC, and Raw. Our data also show that for clinical measurements, no correction for the filter's resistance or 55 mL of dead-space, which were similar between filters, need be applied.
The overall effect of the filter on the measurements of ventilatory function, however, was to reduce FEV, many organisms, including Streptococcus species, Klebsiella pneumoniae, and a variety of fungi. Nonpathogenic organisms were recovered from the breathing tubes of three wedge-bellows spirometers in routine use.14 Lung function equipment has also been linked to the transmission of microorganisms. Isles et al'5 reported an unusually high incidence of Pseudomonas cepacia infection in patients with cystic fibrosis sharing a spirometer, and Hazaleus et al'6 reported the possible transmission of M tuberculosis via a rolling seal spirometer.
Similar studies do not appear to have been conducted on pneumotachograph-type spirometers that are in routine use in most lung function laboratories. These spirometers utilize a resistive element consisting of a fine mesh screen or bundle of capillaries, sited a few centimeters from the mouth, through which the patient exhales and inhales. The risk of contamination from such spirometers is theoretically much greater than for a bellows or rolling seal system as expired fluid can be readily trapped onto the fine mesh surface or within the capillaries that could then be inhaled by subsequent patients. In a busy laboratory, it is impractical to decontaminate the resistive element of the pneumotachograph between patients. The only effective method of preventing their contamination and hence potential to transmit diseases is to prevent microorganisms entering the equipment in the first place.
Despite the lack of direct evidence of disease transmission but because of the heightened anxiety associated with the "AIDS epidemic" and increasing incidence of multiple drug-resistant pulmonary tuberculosis, many laboratories are reviewing their cleaning and disinfection protocols or are looking at other solutions (such as a filter) to the problem of potential equipment contamination. We believe that despite the effect of the filter (PF30S) on PEFR, it can be used with lung function testing equipment without adversely affecting the clinical measurements of lung function across a very wide range.
